As of 2024-12-13, the Relative Valuation of KemPharm Inc (KMPH) is (28.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.81 USD, the upside of KemPharm Inc based on Relative Valuation is -591.1%.
The range of the Relative Valuation is (17.94) - (28.53) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.9x - 23.7x | 22.5x |
| Forward P/E multiples | 14.9x - 25.5x | 24.9x |
| Fair Price | (17.94) - (28.53) | (28.53) |
| Upside | -408.8% - -591.1% | -591.1% |
| Date | P/E |